Clinical Trials
12 trialsNCT02186847 2026-05-22
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
NRG Oncology
Phase 2 Completed
NCT05445791 2026-04-09
METLUNG
Instituto Nacional de Cancerologia de Mexico
Phase 3 Recruiting
NCT04170959 2021-01-15
RADFORMIN
University Hospital, Antwerp
Phase 2 Terminated
NCT03048500 2020-10-14
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Northwestern University
Phase 2 Unknown
NCT03086733 2020-08-19
Metcore
University Health Network, Toronto
Phase 2 Completed
NCT02115464 2020-04-22
ALMERA
Ontario Clinical Oncology Group (OCOG)
Phase 2 Terminated
NCT01717482 2020-03-10
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Mayo Clinic
Phase 2 Terminated
NCT02285855 2020-01-06
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03874000 2019-03-19
SMART
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT01578551 2018-12-19
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01864681 2018-06-20
CGMT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
NCT01997775 2016-09-30
Metformin in Stage IV Lung Adenocarcinoma
National Cheng-Kung University Hospital
Phase 2 Terminated